Search Results

There are 496087 results for: content related to: Choosing an appropriate control group for an observational study design

  1. USP suspected herbal hepatotoxicity: Quality of causality assessment is more important than quantity of counted cases, not vice versa

    Pharmacoepidemiology and Drug Safety

    Volume 21, Issue 3, March 2012, Pages: 336–338, Rolf Teschke, Wolfgang Schmidt-Taenzer and Albrecht Wolff

    Version of Record online : 8 MAR 2012, DOI: 10.1002/pds.3209

  2. What makes the phenolphthalein still be a safe drug for patients in China?

    Pharmacoepidemiology and Drug Safety

    Volume 24, Issue 5, May 2015, Pages: 555–557, Baofang Liang, Jianmin Zou and Jianwei Su

    Version of Record online : 23 APR 2015, DOI: 10.1002/pds.3777

  3. Terms used in patient safety related to medication: a literature review

    Pharmacoepidemiology and Drug Safety

    Volume 21, Issue 8, August 2012, Pages: 799–809, Antonio Pintor-Mármol, María Isabel Baena, Paloma C. Fajardo, Daniel Sabater-Hernández, Loreto Sáez-Benito, María Victoria García-Cárdenas, Narjis Fikri-Benbrahim, Inés Azpilicueta and Maria José Faus

    Version of Record online : 8 JUN 2012, DOI: 10.1002/pds.3296

  4. The renal elimination of apixaban: the totality of data relating to the renal clearance of apixaban in patients with impaired renal function: response to Hellfritzschet al.

    Pharmacoepidemiology and Drug Safety

    Volume 26, Issue 5, May 2017, Pages: 603–605, Wonkyung Byon, Brenda Cirincione, Gregory Di Russo, Frank LaCreta and Rebecca Boyd

    Version of Record online : 25 APR 2017, DOI: 10.1002/pds.4163

  5. Reply to Drs. Nauta and van Domburg

    Pharmacoepidemiology and Drug Safety

    Volume 21, Issue 3, March 2012, Page: 342, Jari Haukka, Leo Niskanen, Timo Partonen, Jouko Lönnqvist and Jari Tiihonen

    Version of Record online : 8 MAR 2012, DOI: 10.1002/pds.3222

  6. Community pharmacists' adoption of medicines reclassified from prescription-only status: a systematic review of factors associated with decision making

    Pharmacoepidemiology and Drug Safety

    Volume 21, Issue 4, April 2012, Pages: 396–406, Vibhu Paudyal, Denise Hansford, Scott Cunningham and Derek Stewart

    Version of Record online : 23 FEB 2012, DOI: 10.1002/pds.3219

  7. Use of domperidone and risk of ventricular arrhythmia in the postpartum period: getting to the heart of the matter

    Pharmacoepidemiology and Drug Safety

    Volume 26, Issue 7, July 2017, Pages: 863–864, Luke E. Grzeskowiak and Lisa G. Smithers

    Version of Record online : 3 JUL 2017, DOI: 10.1002/pds.4133

  8. Reply letter: are FDA prescription drug safety plans working? A case study of isotretinoin

    Pharmacoepidemiology and Drug Safety

    Volume 23, Issue 4, April 2014, Pages: 440–441, Kevin Fain and G. Caleb Alexander

    Version of Record online : 5 APR 2014, DOI: 10.1002/pds.3577

  9. Response to Teschke et al.

    Pharmacoepidemiology and Drug Safety

    Volume 21, Issue 3, March 2012, Pages: 339–340, Gail Mahady, Tieraona Low Dog, Nandakumara D. Sarma, James Griffiths and Gabriel I. Giancaspro

    Version of Record online : 8 MAR 2012, DOI: 10.1002/pds.3210

    Corrected by:

    Erratum: Erratum

    Vol. 21, Issue 7, 787, Version of Record online: 4 JUL 2012

  10. Misconceptions regarding the association between Herbalife products and liver-related case reports in Spain

    Pharmacoepidemiology and Drug Safety

    Volume 21, Issue 3, March 2012, Pages: 333–334, Kristy Appelhans, Vasilios Frankos and Andrew Shao

    Version of Record online : 8 MAR 2012, DOI: 10.1002/pds.3203

  11. Post-market drug safety evidence sources: an analysis of FDA drug safety communications

    Pharmacoepidemiology and Drug Safety

    Volume 21, Issue 10, October 2012, Pages: 1134–1136, Chieko Ishiguro, Marni Hall, George A. Neyarapally and Gerald Dal Pan

    Version of Record online : 3 OCT 2012, DOI: 10.1002/pds.3317

  12. The validity and reliability of a signal impact assessment tool: statistical issue to avoid misinterpretation

    Pharmacoepidemiology and Drug Safety

    Volume 25, Issue 10, October 2016, Pages: 1215–1216, Siamak Sabour and Fariba Ghassemi

    Version of Record online : 3 OCT 2016, DOI: 10.1002/pds.4061

  13. Erratum to ‘Epidemiology of potentially inappropriate medication use in elderly patients in Japanese acute care hospitals’ and ‘Clinical prediction rule to identify high-risk inpatients for adverse drug events: the JADE Study’

    Pharmacoepidemiology and Drug Safety

    Volume 22, Issue 11, November 2013, Page: 1245, Takeshi Morimoto, Mio Sakuma and David W. Bates

    Version of Record online : 21 OCT 2013, DOI: 10.1002/pds.3524

  14. Diclofenac: increase of myocardial infarctions at low doses?

    Pharmacoepidemiology and Drug Safety

    Volume 23, Issue 3, March 2014, Pages: 326–328, Kay Brune

    Version of Record online : 4 MAR 2014, DOI: 10.1002/pds.3564

  15. Temporal relationship between multiple drugs and multiple events in patient reports on adverse drug reactions: findings in a pilot study in Japan

    Pharmacoepidemiology and Drug Safety

    Volume 22, Issue 10, October 2013, Pages: 1134–1137, Kiyoshi Kubota, Mitsuhiro Okazaki, Akira Dobashi, Michiko Yamamoto, Masayuki Hashiguchi, Arisa Horie, Ataru Inagaki, Toshiaki Kikuchi and Mayumi Mochizuki

    Version of Record online : 1 OCT 2013, DOI: 10.1002/pds.3490

  16. Additional data on citalopram and the risk of sudden cardiac death and ventricular arrhythmia

    Pharmacoepidemiology and Drug Safety

    Volume 21, Issue 3, March 2012, Pages: 331–332, Charles E. Leonard, Warren B. Bilker, Craig Newcomb, Stephen E. Kimmel and Sean Hennessy

    Version of Record online : 8 MAR 2012, DOI: 10.1002/pds.2352

  17. Author's reply

    Pharmacoepidemiology and Drug Safety

    Volume 21, Issue 3, March 2012, Page: 335, Gloria Manso

    Version of Record online : 8 MAR 2012, DOI: 10.1002/pds.3201

  18. Utilisation of transdermal fentanyl in Germany from 2004–2006 by Edeltraut Garbe and colleagues

    Pharmacoepidemiology and Drug Safety

    Volume 21, Issue 8, August 2012, Pages: 902–903, Rainer Sabatowski and Rüdiger Scharnagel

    Version of Record online : 26 JUL 2012, DOI: 10.1002/pds.3315

  19. Use of thiazolidinediones and risk of osteoporotic fracture: disease or drugs?

    Pharmacoepidemiology and Drug Safety

    Volume 21, Issue 5, May 2012, Pages: 507–514, Marloes T. Bazelier, Arlene M. Gallagher, Tjeerd-Pieter van Staa, Cyrus Cooper, Hubert G. M. Leufkens, Peter Vestergaard and Frank de Vries

    Version of Record online : 6 MAR 2012, DOI: 10.1002/pds.3234

  20. You have free access to this content
    When to randomize, or ‘Evidence-based medicine needs Medicine-based evidence’

    Pharmacoepidemiology and Drug Safety

    Volume 21, Issue S2, May 2012, Pages: 6–12, John Concato

    Version of Record online : 3 MAY 2012, DOI: 10.1002/pds.3245